nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxtriphylline—PDE4D—esophageal cancer	0.799	1	CbGaD
Oxtriphylline—HDAC2—exocrine gland—esophageal cancer	0.00396	0.0918	CbGeAlD
Oxtriphylline—HDAC2—neck—esophageal cancer	0.00253	0.0587	CbGeAlD
Oxtriphylline—ADORA2B—bronchus—esophageal cancer	0.00239	0.0554	CbGeAlD
Oxtriphylline—ADORA2B—smooth muscle tissue—esophageal cancer	0.00234	0.0542	CbGeAlD
Oxtriphylline—Caffeine—PIK3CA—esophageal cancer	0.0023	0.283	CrCbGaD
Oxtriphylline—Dyphylline—PDE4D—esophageal cancer	0.00215	0.264	CrCbGaD
Oxtriphylline—ADORA2B—trachea—esophageal cancer	0.00214	0.0498	CbGeAlD
Oxtriphylline—PDE3B—lung—esophageal cancer	0.00186	0.0432	CbGeAlD
Oxtriphylline—PDE3A—smooth muscle tissue—esophageal cancer	0.00172	0.04	CbGeAlD
Oxtriphylline—HDAC2—epithelium—esophageal cancer	0.00172	0.0399	CbGeAlD
Oxtriphylline—HDAC2—bronchus—esophageal cancer	0.00169	0.0393	CbGeAlD
Oxtriphylline—HDAC2—smooth muscle tissue—esophageal cancer	0.00166	0.0385	CbGeAlD
Oxtriphylline—PDE4D—lung—esophageal cancer	0.00155	0.036	CbGeAlD
Oxtriphylline—ADORA2B—lung—esophageal cancer	0.00154	0.0358	CbGeAlD
Oxtriphylline—Theophylline—PDE4D—esophageal cancer	0.00153	0.188	CrCbGaD
Oxtriphylline—SLC22A7—digestive system—esophageal cancer	0.00152	0.0353	CbGeAlD
Oxtriphylline—PDE4A—lung—esophageal cancer	0.00137	0.0319	CbGeAlD
Oxtriphylline—HDAC2—digestive system—esophageal cancer	0.00131	0.0304	CbGeAlD
Oxtriphylline—PDE3B—lymph node—esophageal cancer	0.00127	0.0295	CbGeAlD
Oxtriphylline—PDE4B—bronchus—esophageal cancer	0.00127	0.0295	CbGeAlD
Oxtriphylline—PDE4B—trachea—esophageal cancer	0.00114	0.0264	CbGeAlD
Oxtriphylline—PDE3A—lung—esophageal cancer	0.00114	0.0264	CbGeAlD
Oxtriphylline—ADORA1—lung—esophageal cancer	0.00111	0.0257	CbGeAlD
Oxtriphylline—HDAC2—lung—esophageal cancer	0.00109	0.0254	CbGeAlD
Oxtriphylline—PDE4D—lymph node—esophageal cancer	0.00106	0.0246	CbGeAlD
Oxtriphylline—Theophylline—CYP1B1—esophageal cancer	0.000955	0.117	CrCbGaD
Oxtriphylline—PDE4A—lymph node—esophageal cancer	0.000939	0.0218	CbGeAlD
Oxtriphylline—Caffeine—CYP1B1—esophageal cancer	0.000937	0.115	CrCbGaD
Oxtriphylline—PDE4B—lung—esophageal cancer	0.000819	0.019	CbGeAlD
Oxtriphylline—PDE3A—lymph node—esophageal cancer	0.000777	0.018	CbGeAlD
Oxtriphylline—ADORA1—lymph node—esophageal cancer	0.000757	0.0176	CbGeAlD
Oxtriphylline—HDAC2—lymph node—esophageal cancer	0.000748	0.0174	CbGeAlD
Oxtriphylline—CYP1A2—digestive system—esophageal cancer	0.000602	0.014	CbGeAlD
Oxtriphylline—PDE4B—lymph node—esophageal cancer	0.00056	0.013	CbGeAlD
Oxtriphylline—CYP1A2—lung—esophageal cancer	0.000503	0.0117	CbGeAlD
Oxtriphylline—Caffeine—ABCB1—esophageal cancer	0.000269	0.033	CrCbGaD
Oxtriphylline—HDAC2—Signaling Pathways—PSME1—esophageal cancer	2.83e-05	0.000189	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—ANXA1—esophageal cancer	2.81e-05	0.000188	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—CXCL2—esophageal cancer	2.81e-05	0.000188	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—SMAD4—esophageal cancer	2.76e-05	0.000185	CbGpPWpGaD
Oxtriphylline—PDE3B—Hemostasis—PIK3CA—esophageal cancer	2.74e-05	0.000183	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—SST—esophageal cancer	2.74e-05	0.000183	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—TGFBR2—esophageal cancer	2.73e-05	0.000183	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—SMAD4—esophageal cancer	2.71e-05	0.000182	CbGpPWpGaD
Oxtriphylline—HDAC2—Hemostasis—EP300—esophageal cancer	2.7e-05	0.000181	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—GHRL—esophageal cancer	2.67e-05	0.000179	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—NOTCH3—esophageal cancer	2.67e-05	0.000179	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—TGFBR2—esophageal cancer	2.66e-05	0.000178	CbGpPWpGaD
Oxtriphylline—PDE3B—Hemostasis—TP53—esophageal cancer	2.65e-05	0.000177	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—PSME2—esophageal cancer	2.63e-05	0.000176	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—PSME1—esophageal cancer	2.63e-05	0.000176	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—FBXW7—esophageal cancer	2.62e-05	0.000176	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—ANXA1—esophageal cancer	2.62e-05	0.000175	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—SMAD4—esophageal cancer	2.58e-05	0.000173	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—TGFBR2—esophageal cancer	2.56e-05	0.000171	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—HIF1A—esophageal cancer	2.55e-05	0.000171	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—SST—esophageal cancer	2.55e-05	0.00017	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—TGFBR2—esophageal cancer	2.53e-05	0.000169	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—SMAD4—esophageal cancer	2.51e-05	0.000168	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	2.5e-05	0.000168	CbGpPWpGaD
Oxtriphylline—PDE3A—Hemostasis—PIK3CA—esophageal cancer	2.5e-05	0.000167	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—GHRL—esophageal cancer	2.48e-05	0.000166	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—NOTCH3—esophageal cancer	2.48e-05	0.000166	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—FBXW7—esophageal cancer	2.44e-05	0.000163	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—KDR—esophageal cancer	2.44e-05	0.000163	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—SMAD4—esophageal cancer	2.42e-05	0.000162	CbGpPWpGaD
Oxtriphylline—PDE3A—Hemostasis—TP53—esophageal cancer	2.42e-05	0.000162	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—NOTCH2—esophageal cancer	2.39e-05	0.00016	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—SMAD4—esophageal cancer	2.39e-05	0.00016	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—HIF1A—esophageal cancer	2.35e-05	0.000157	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—HIF1A—esophageal cancer	2.33e-05	0.000156	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—NOTCH1—esophageal cancer	2.3e-05	0.000154	CbGpPWpGaD
Oxtriphylline—HDAC2—Gene Expression—NOTCH1—esophageal cancer	2.28e-05	0.000152	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—HIF1A—esophageal cancer	2.26e-05	0.000151	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—KDR—esophageal cancer	2.23e-05	0.000149	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—NOTCH2—esophageal cancer	2.22e-05	0.000149	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—SLC52A3—esophageal cancer	2.22e-05	0.000149	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—BLVRB—esophageal cancer	2.22e-05	0.000149	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—HIF1A—esophageal cancer	2.22e-05	0.000149	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—KDR—esophageal cancer	2.16e-05	0.000145	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—NOS2—esophageal cancer	2.14e-05	0.000143	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—KDR—esophageal cancer	2.12e-05	0.000142	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—TGFBR2—esophageal cancer	2.12e-05	0.000142	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—NOTCH1—esophageal cancer	2.12e-05	0.000142	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—HIF1A—esophageal cancer	2.11e-05	0.000142	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—NOTCH1—esophageal cancer	2.1e-05	0.00014	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—CREBBP—esophageal cancer	2.08e-05	0.000139	CbGpPWpGaD
Oxtriphylline—HDAC2—Gene Expression—CREBBP—esophageal cancer	2.07e-05	0.000138	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—HIF1A—esophageal cancer	2.06e-05	0.000138	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling by GPCR—EGFR—esophageal cancer	2.05e-05	0.000137	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—NOTCH1—esophageal cancer	2.03e-05	0.000136	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—KDR—esophageal cancer	2.02e-05	0.000135	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—SMAD4—esophageal cancer	2.01e-05	0.000134	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—NOTCH1—esophageal cancer	2e-05	0.000134	CbGpPWpGaD
Oxtriphylline—HDAC2—Hemostasis—PIK3CA—esophageal cancer	2e-05	0.000134	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	1.99e-05	0.000133	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—HIF1A—esophageal cancer	1.98e-05	0.000133	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—TGFBR2—esophageal cancer	1.97e-05	0.000132	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—KDR—esophageal cancer	1.97e-05	0.000132	CbGpPWpGaD
Oxtriphylline—PDE4C—GPCR downstream signaling—PIK3CA—esophageal cancer	1.96e-05	0.000131	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—HIF1A—esophageal cancer	1.96e-05	0.000131	CbGpPWpGaD
Oxtriphylline—HDAC2—Hemostasis—TP53—esophageal cancer	1.93e-05	0.000129	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—CREBBP—esophageal cancer	1.92e-05	0.000128	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—NOTCH1—esophageal cancer	1.9e-05	0.000127	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—CREBBP—esophageal cancer	1.9e-05	0.000127	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—KDR—esophageal cancer	1.89e-05	0.000127	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—CA1—esophageal cancer	1.89e-05	0.000127	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—SLC10A2—esophageal cancer	1.89e-05	0.000127	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—KDR—esophageal cancer	1.87e-05	0.000125	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling by GPCR—EGFR—esophageal cancer	1.87e-05	0.000125	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—SMAD4—esophageal cancer	1.87e-05	0.000125	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—NOS3—esophageal cancer	1.87e-05	0.000125	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—NOTCH1—esophageal cancer	1.85e-05	0.000124	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—CREBBP—esophageal cancer	1.84e-05	0.000123	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—CREBBP—esophageal cancer	1.81e-05	0.000121	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling by GPCR—EGFR—esophageal cancer	1.81e-05	0.000121	CbGpPWpGaD
Oxtriphylline—ADORA2B—GPCR downstream signaling—PIK3CA—esophageal cancer	1.79e-05	0.00012	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—NOTCH1—esophageal cancer	1.78e-05	0.000119	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling by GPCR—EGFR—esophageal cancer	1.78e-05	0.000119	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling by GPCR—PIK3CA—esophageal cancer	1.78e-05	0.000119	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—NOTCH1—esophageal cancer	1.76e-05	0.000118	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—ERBB2—esophageal cancer	1.75e-05	0.000117	CbGpPWpGaD
Oxtriphylline—PDE3B—GPCR downstream signaling—PIK3CA—esophageal cancer	1.73e-05	0.000116	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—CA2—esophageal cancer	1.73e-05	0.000116	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—CREBBP—esophageal cancer	1.73e-05	0.000116	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—NOS3—esophageal cancer	1.72e-05	0.000115	CbGpPWpGaD
Oxtriphylline—PDE4D—GPCR downstream signaling—PIK3CA—esophageal cancer	1.7e-05	0.000114	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—NOS3—esophageal cancer	1.7e-05	0.000114	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling by GPCR—EGFR—esophageal cancer	1.7e-05	0.000114	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	1.69e-05	0.000113	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—CREBBP—esophageal cancer	1.68e-05	0.000112	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—NOS3—esophageal cancer	1.65e-05	0.000111	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling by GPCR—EGFR—esophageal cancer	1.65e-05	0.00011	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—HIF1A—esophageal cancer	1.64e-05	0.00011	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—NOS3—esophageal cancer	1.62e-05	0.000109	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling by GPCR—PIK3CA—esophageal cancer	1.62e-05	0.000109	CbGpPWpGaD
Oxtriphylline—PDE4A—GPCR downstream signaling—PIK3CA—esophageal cancer	1.62e-05	0.000109	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—CREBBP—esophageal cancer	1.62e-05	0.000108	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—PLCE1—esophageal cancer	1.61e-05	0.000108	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—ADH7—esophageal cancer	1.61e-05	0.000108	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—ERBB2—esophageal cancer	1.61e-05	0.000107	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—CREBBP—esophageal cancer	1.6e-05	0.000107	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—ERBB2—esophageal cancer	1.59e-05	0.000107	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	1.59e-05	0.000106	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—EGFR—esophageal cancer	1.59e-05	0.000106	CbGpPWpGaD
Oxtriphylline—PDE3A—GPCR downstream signaling—PIK3CA—esophageal cancer	1.58e-05	0.000106	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling by GPCR—PIK3CA—esophageal cancer	1.57e-05	0.000105	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—KDR—esophageal cancer	1.57e-05	0.000105	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—PTGS2—esophageal cancer	1.57e-05	0.000105	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—EGFR—esophageal cancer	1.57e-05	0.000105	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling by GPCR—PIK3CA—esophageal cancer	1.55e-05	0.000104	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—NOS3—esophageal cancer	1.55e-05	0.000103	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—ERBB2—esophageal cancer	1.54e-05	0.000103	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—CCND1—esophageal cancer	1.54e-05	0.000103	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—HIF1A—esophageal cancer	1.53e-05	0.000102	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—ERBB2—esophageal cancer	1.52e-05	0.000102	CbGpPWpGaD
Oxtriphylline—ADORA1—GPCR downstream signaling—PIK3CA—esophageal cancer	1.52e-05	0.000102	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—NOS3—esophageal cancer	1.5e-05	0.000101	CbGpPWpGaD
Oxtriphylline—PDE4B—GPCR downstream signaling—PIK3CA—esophageal cancer	1.5e-05	0.0001	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—CDKN1A—esophageal cancer	1.49e-05	9.98e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—NOTCH1—esophageal cancer	1.48e-05	9.91e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling by GPCR—PIK3CA—esophageal cancer	1.47e-05	9.86e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—KDR—esophageal cancer	1.46e-05	9.78e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—NOS3—esophageal cancer	1.45e-05	9.69e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—ERBB2—esophageal cancer	1.45e-05	9.68e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling by GPCR—PIK3CA—esophageal cancer	1.43e-05	9.59e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—NOS3—esophageal cancer	1.43e-05	9.58e-05	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—EP300—esophageal cancer	1.42e-05	9.5e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—ADH1B—esophageal cancer	1.41e-05	9.44e-05	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—CCND1—esophageal cancer	1.41e-05	9.42e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—ERBB2—esophageal cancer	1.41e-05	9.42e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—PIK3CA—esophageal cancer	1.38e-05	9.23e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—NOTCH1—esophageal cancer	1.38e-05	9.22e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—CDKN1A—esophageal cancer	1.37e-05	9.19e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—CCND1—esophageal cancer	1.36e-05	9.13e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—PIK3CA—esophageal cancer	1.36e-05	9.12e-05	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—CDKN1A—esophageal cancer	1.36e-05	9.11e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—ERBB2—esophageal cancer	1.35e-05	9.06e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—TYMP—esophageal cancer	1.35e-05	9.02e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—CREBBP—esophageal cancer	1.34e-05	8.99e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—CCND1—esophageal cancer	1.34e-05	8.98e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—ERBB2—esophageal cancer	1.34e-05	8.96e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—CDKN1A—esophageal cancer	1.32e-05	8.84e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—CYP26A1—esophageal cancer	1.31e-05	8.77e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—EP300—esophageal cancer	1.31e-05	8.74e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—CDKN1A—esophageal cancer	1.3e-05	8.69e-05	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—EP300—esophageal cancer	1.3e-05	8.67e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—CCND1—esophageal cancer	1.28e-05	8.55e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—ALOX15—esophageal cancer	1.28e-05	8.55e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—EP300—esophageal cancer	1.26e-05	8.41e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—CREBBP—esophageal cancer	1.25e-05	8.36e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—CCND1—esophageal cancer	1.24e-05	8.32e-05	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—MYC—esophageal cancer	1.24e-05	8.28e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—CDKN1A—esophageal cancer	1.24e-05	8.27e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—EP300—esophageal cancer	1.24e-05	8.27e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—EGFR—esophageal cancer	1.23e-05	8.21e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Gene Expression—MYC—esophageal cancer	1.23e-05	8.2e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—TPI1—esophageal cancer	1.22e-05	8.16e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—GSTO1—esophageal cancer	1.22e-05	8.16e-05	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—EGFR—esophageal cancer	1.21e-05	8.1e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—NOS3—esophageal cancer	1.2e-05	8.05e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—CDKN1A—esophageal cancer	1.2e-05	8.05e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—CCND1—esophageal cancer	1.2e-05	8.01e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—CCND1—esophageal cancer	1.18e-05	7.91e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—EP300—esophageal cancer	1.18e-05	7.87e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—GPCR downstream signaling—PIK3CA—esophageal cancer	1.17e-05	7.85e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—ALDOB—esophageal cancer	1.17e-05	7.82e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—CDKN1A—esophageal cancer	1.16e-05	7.75e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—EP300—esophageal cancer	1.14e-05	7.66e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—CDKN1A—esophageal cancer	1.14e-05	7.65e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—MYC—esophageal cancer	1.14e-05	7.62e-05	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—MYC—esophageal cancer	1.13e-05	7.55e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—GAPDH—esophageal cancer	1.12e-05	7.53e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—ERBB2—esophageal cancer	1.12e-05	7.53e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—NOS3—esophageal cancer	1.12e-05	7.48e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—CRABP1—esophageal cancer	1.11e-05	7.46e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—EGFR—esophageal cancer	1.11e-05	7.45e-05	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—EGFR—esophageal cancer	1.1e-05	7.39e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—EP300—esophageal cancer	1.1e-05	7.37e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—MYC—esophageal cancer	1.09e-05	7.33e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—EP300—esophageal cancer	1.09e-05	7.28e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—MYC—esophageal cancer	1.08e-05	7.21e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—EGFR—esophageal cancer	1.07e-05	7.17e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—PIK3CA—esophageal cancer	1.06e-05	7.13e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—GNG7—esophageal cancer	1.06e-05	7.1e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—EGFR—esophageal cancer	1.05e-05	7.05e-05	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—PIK3CA—esophageal cancer	1.05e-05	7.03e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—ERBB2—esophageal cancer	1.05e-05	7e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—MYC—esophageal cancer	1.02e-05	6.86e-05	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—TP53—esophageal cancer	1.02e-05	6.8e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—EGFR—esophageal cancer	1e-05	6.71e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—MYC—esophageal cancer	9.97e-06	6.67e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—CCND1—esophageal cancer	9.94e-06	6.65e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—ALDH2—esophageal cancer	9.94e-06	6.65e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—EGFR—esophageal cancer	9.75e-06	6.53e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—PIK3CA—esophageal cancer	9.66e-06	6.47e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—CDKN1A—esophageal cancer	9.61e-06	6.43e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—MYC—esophageal cancer	9.6e-06	6.42e-05	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—PIK3CA—esophageal cancer	9.58e-06	6.41e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—MYC—esophageal cancer	9.48e-06	6.35e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—GSTT1—esophageal cancer	9.45e-06	6.32e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—EGFR—esophageal cancer	9.39e-06	6.28e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—CYP2A6—esophageal cancer	9.34e-06	6.25e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	9.31e-06	6.23e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—PIK3CA—esophageal cancer	9.29e-06	6.22e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—EGFR—esophageal cancer	9.28e-06	6.21e-05	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—TP53—esophageal cancer	9.27e-06	6.2e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—CCND1—esophageal cancer	9.24e-06	6.18e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—EP300—esophageal cancer	9.15e-06	6.12e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—PIK3CA—esophageal cancer	9.14e-06	6.12e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—TP53—esophageal cancer	8.99e-06	6.02e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—CDKN1A—esophageal cancer	8.94e-06	5.98e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—ENO1—esophageal cancer	8.86e-06	5.93e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—PTGS1—esophageal cancer	8.86e-06	5.93e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—TP53—esophageal cancer	8.84e-06	5.92e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—PSME2—esophageal cancer	8.73e-06	5.84e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—PSME1—esophageal cancer	8.73e-06	5.84e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—PIK3CA—esophageal cancer	8.7e-06	5.82e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—EP300—esophageal cancer	8.5e-06	5.69e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—PIK3CA—esophageal cancer	8.46e-06	5.66e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—TP53—esophageal cancer	8.42e-06	5.63e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—TP53—esophageal cancer	8.19e-06	5.48e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—PIK3CA—esophageal cancer	8.15e-06	5.45e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—PIK3CA—esophageal cancer	8.05e-06	5.39e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—MYC—esophageal cancer	7.97e-06	5.33e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—TP53—esophageal cancer	7.88e-06	5.28e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—EGFR—esophageal cancer	7.8e-06	5.22e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—TP53—esophageal cancer	7.79e-06	5.21e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	7.62e-06	5.1e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—CYP1B1—esophageal cancer	7.53e-06	5.04e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—MYC—esophageal cancer	7.41e-06	4.96e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—EGFR—esophageal cancer	7.25e-06	4.85e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—CYP19A1—esophageal cancer	7.08e-06	4.74e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—PIK3CA—esophageal cancer	6.77e-06	4.53e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—TP53—esophageal cancer	6.55e-06	4.38e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—HMOX1—esophageal cancer	6.46e-06	4.32e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	6.34e-06	4.24e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—PIK3CA—esophageal cancer	6.29e-06	4.21e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—ABCB1—esophageal cancer	6.2e-06	4.15e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—TP53—esophageal cancer	6.09e-06	4.07e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.69e-06	3.14e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—CREBBP—esophageal cancer	4.14e-06	2.77e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—NOS3—esophageal cancer	3.71e-06	2.48e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—PTGS2—esophageal cancer	3.39e-06	2.27e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—EP300—esophageal cancer	2.82e-06	1.89e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—PIK3CA—esophageal cancer	2.09e-06	1.4e-05	CbGpPWpGaD
